Aug 14 (Reuters)-
Enbio Holdings, Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2024 Jun 30, 2023 Mar 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 3.00 3.42 10.76
(-12.4 pct) (+28.3 pct) (+12.4 pct)
Operating 395 mln 240 mln 604 mln
(+64.6 pct) (-66.4 pct) (-25.9 pct)
Recurring 513 mln 345 mln 508 mln
(+48.7 pct) (-57.4 pct) (-52.4 pct)
Net 351 mln 170 mln 340 mln
(+106.0 pct) (-64.4 pct) (-51.9 pct)
EPS 43.25 yen 22.79 yen 41.90 yen
Ann Div 8.00 yen 8.00 yen
-Q2 div NIL NIL
-Q4 div 8.00 yen 8.00 yen
NOTE - Enbio Holdings, Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6092.T